NCT02595463View on ClinicalTrials.gov

Intravenous Lidocaine for Post-Tonsillectomy Pain in Pediatric Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

June 5, 2024

Study Completion Date

July 5, 2024

Conditions
Pain
Interventions
DRUG

Lidocaine

Intraoperative dose of intravenous lidocaine followed by an infusion until discharge from the initial recovery period.

DRUG

Saline

Intraoperative dose of saline followed by an infusion until discharge from the initial recovery period.

Trial Locations (1)

60611

Ann & Robert H. Lurie Children's Hospital, Chicago

All Listed Sponsors
lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

NCT02595463 - Intravenous Lidocaine for Post-Tonsillectomy Pain in Pediatric Patients | Biotech Hunter | Biotech Hunter